CXCL12 and neoplasm: Accordingly, we found that treatment-induced upregulation of GRP183 in BL tumors strongly affect F-actin polymerization in B cells, with the consequent impairment of CXCL12-dependent chemotaxis, a phenomenon that possibly render these latter more accessible to pro-inflammatory macrophages with the capacity to limit tumor growth (42).